Error message

EDS Server Issue
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res Subsets: MEDLINE
    • Publication Information:
      Publication: 2005- : Netherlands : Springer Netherlands
      Original Publication: Oxford, UK : Rapid Communications of Oxford, Ltd, c1992-
    • Subject Terms:
    • Abstract:
      Purpose: Ecological momentary assessment (EMA) may help us better understand biopsychosocial determinants and outcomes of physical activity during chemotherapy, but may be burdensome for patients. The purpose of this study was to determine the feasibility and acceptability of using EMA to assess activity, symptoms, and motivation among early-stage breast cancer patients undergoing chemotherapy.
      Methods: Women were instructed to wear an accelerometer 24/7 (hip during day and wrist overnight). Text message prompts were sent 4 times/day concerning patient-reported symptoms and motivational factors for 10 consecutive days (3 days pre-, day of, and 6 days post-chemotherapy dose). These measures occurred at the beginning, middle, and end of a full course of chemotherapy. At study conclusion, participants reported on perceived study acceptability, burden, and reactivity.
      Results: Of the 75 women who consented to participate, 63 (84%) completed all 3 assessment time points. Participants responded to 86% of total text prompts and had valid accelerometer data on 82% of study days. Compliance was similar across all time points. The majority (78%) rated their study experience as positive; 100% were confident in their ability to use study technology. Reactivity varied with 27% indicating answering symptom questions did not affect how they felt and 44% and 68% indicated answering questions and wearing the accelerometer, respectively, made them want to increase activity.
      Conclusions: Findings indicate EMA methods are feasible for breast cancer patients undergoing chemotherapy. EMA may help us better understand the biopsychosocial processes underlying breast cancer patients' activity in the context of daily life.
    • References:
      Obesity (Silver Spring). 2011 Jun;19(6):1205-12. (PMID: 21164502)
      J Pain Symptom Manage. 2007 Mar;33(3):267-75. (PMID: 17349496)
      BMC Public Health. 2014 Feb 15;14:168. (PMID: 24528783)
      Can J Appl Sport Sci. 1985 Sep;10(3):141-6. (PMID: 4053261)
      Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S471-80. (PMID: 10993417)
      Ann Behav Med. 2002 Spring;24(2):149-56. (PMID: 12054320)
      Medicine (Baltimore). 2016 Oct;95(40):e4629. (PMID: 27749527)
      Eur J Dermatol. 2016 Oct 1;26(5):427-443. (PMID: 27550571)
      Eur J Oncol Nurs. 2016 Apr;21:160-7. (PMID: 26463702)
      Am J Clin Nutr. 2016 Nov;104(5):1424-1432. (PMID: 27707702)
      Med Sci Sports Exerc. 2008 Jan;40(1):181-8. (PMID: 18091006)
      Support Care Cancer. 2017 Aug;25(8):2495-2503. (PMID: 28326507)
      Med Sci Sports Exerc. 2014 Sep;46(9):1744-51. (PMID: 24633595)
      Med Sci Sports Exerc. 2012 Jan;44(1 Suppl 1):S13-23. (PMID: 22157770)
      Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):379-86. (PMID: 18250341)
      Cancer. 2003 Apr 1;97(7):1746-57. (PMID: 12655532)
      Nicotine Tob Res. 2014 May;16 Suppl 2:S73-5. (PMID: 24711629)
      Breast. 2018 Aug;40:23-28. (PMID: 29674221)
      J Cancer Surviv. 2010 Jun;4(2):119-27. (PMID: 20180037)
      JMIR Mhealth Uhealth. 2018 Feb 19;6(2):e21. (PMID: 29459355)
      Pain. 2003 Jul;104(1-2):343-51. (PMID: 12855344)
      Front Psychol. 2012 Jul 30;3:260. (PMID: 22866046)
      J Clin Epidemiol. 2011 May;64(5):507-16. (PMID: 21447427)
      Front Psychol. 2018 Aug 15;9:1485. (PMID: 30158891)
      J Community Support Oncol. 2016 May;14(5):200-9. (PMID: 27258052)
      Support Care Cancer. 2014 Apr;22(4):1121-30. (PMID: 24389829)
      Med Care. 2007 May;45(5 Suppl 1):S3-S11. (PMID: 17443116)
      Ann Behav Med. 2011 Dec;42(3):321-33. (PMID: 21785899)
      J Cancer Surviv. 2010 Jun;4(2):87-100. (PMID: 20052559)
      J Clin Oncol. 2015 Jun 10;33(17):1918-27. (PMID: 25918291)
      Semin Oncol Nurs. 2016 Nov;32(4):383-393. (PMID: 27776835)
      J Behav Med. 1993 Feb;16(1):103-13. (PMID: 8433355)
      Am J Clin Nutr. 2012 Feb;95(2):437-45. (PMID: 22218159)
      Support Care Cancer. 2010 Dec;18(12):1539-44. (PMID: 19956982)
      Qual Life Res. 2017 Mar;26(3):587-600. (PMID: 28097459)
    • Contributed Indexing:
      Keywords: Breast cancer; Chemotherapy; Patient-reported outcomes; Physical activity; mHealth
    • Publication Date:
      Date Created: 20190908 Date Completed: 20200203 Latest Revision: 20200203
    • Publication Date:
      20200827
    • Accession Number:
      10.1007/s11136-019-02278-7
    • Accession Number:
      31493269
  • Citations
    • ABNT:
      SOLK, P. et al. Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, [s. l.], v. 28, n. 12, p. 3333–3346, 2019. DOI 10.1007/s11136-019-02278-7. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdc&AN=31493269. Acesso em: 23 set. 2020.
    • AMA:
      Solk P, Gavin K, Fanning J, et al. Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2019;28(12):3333-3346. doi:10.1007/s11136-019-02278-7
    • APA:
      Solk, P., Gavin, K., Fanning, J., Welch, W., Lloyd, G., Cottrell, A., Nielsen, A., Santa Maria, C. A., Gradishar, W., Khan, S. A., Kulkarni, S., Siddique, J., & Phillips, S. M. (2019). Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 28(12), 3333–3346. https://doi.org/10.1007/s11136-019-02278-7
    • Chicago/Turabian: Author-Date:
      Solk, Payton, Kara Gavin, Jason Fanning, Whitney Welch, Gillian Lloyd, Alison Cottrell, Anne Nielsen, et al. 2019. “Feasibility and Acceptability of Intensive Longitudinal Data Collection of Activity and Patient-Reported Outcomes during Chemotherapy for Breast Cancer.” Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 28 (12): 3333–46. doi:10.1007/s11136-019-02278-7.
    • Harvard:
      Solk, P. et al. (2019) ‘Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer’, Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 28(12), pp. 3333–3346. doi: 10.1007/s11136-019-02278-7.
    • Harvard: Australian:
      Solk, P, Gavin, K, Fanning, J, Welch, W, Lloyd, G, Cottrell, A, Nielsen, A, Santa Maria, CA, Gradishar, W, Khan, SA, Kulkarni, S, Siddique, J & Phillips, SM 2019, ‘Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer’, Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, vol. 28, no. 12, pp. 3333–3346, viewed 23 September 2020, .
    • MLA:
      Solk, Payton, et al. “Feasibility and Acceptability of Intensive Longitudinal Data Collection of Activity and Patient-Reported Outcomes during Chemotherapy for Breast Cancer.” Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, vol. 28, no. 12, Dec. 2019, pp. 3333–3346. EBSCOhost, doi:10.1007/s11136-019-02278-7.
    • Chicago/Turabian: Humanities:
      Solk, Payton, Kara Gavin, Jason Fanning, Whitney Welch, Gillian Lloyd, Alison Cottrell, Anne Nielsen, et al. “Feasibility and Acceptability of Intensive Longitudinal Data Collection of Activity and Patient-Reported Outcomes during Chemotherapy for Breast Cancer.” Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 28, no. 12 (December 2019): 3333–46. doi:10.1007/s11136-019-02278-7.
    • Vancouver/ICMJE:
      Solk P, Gavin K, Fanning J, Welch W, Lloyd G, Cottrell A, et al. Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Internet]. 2019 Dec [cited 2020 Sep 23];28(12):3333–46. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdc&AN=31493269